Register entry
Vitruvias Therapeutics, Inc.
- Registered sites
- 0
- Drug products
- 30
- Live patents
- 0
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Catalogue
Marketed products
30Showing 30 of 30.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| Aminocaproic Acid | Aminocaproic Acid | SOLUTION | ANDA |
| Aminocaproic Acid | Aminocaproic Acid | TABLET | ANDA |
| Aminocaproic Acid | Aminocaproic Acid | TABLET | ANDA |
| Bupropion hydrochloride (XL) | Bupropion hydrochloride | TABLET, EXTENDED RELEASE | ANDA |
| Bupropion hydrochloride (XL) | Bupropion hydrochloride | TABLET, EXTENDED RELEASE | ANDA |
| Cyanocobalamin | Cyanocobalamin | INJECTION, SOLUTION | ANDA |
| Cyanocobalamin | Cyanocobalamin | INJECTION, SOLUTION | ANDA |
| Cyanocobalamin | Cyanocobalamin | INJECTION, SOLUTION | ANDA |
| Icosapent Ethyl | Icosapent Ethyl | CAPSULE | ANDA |
| Memantine Hydrochloride | memantine hydrochloride | CAPSULE, EXTENDED RELEASE | ANDA |
| Memantine Hydrochloride | memantine hydrochloride | CAPSULE, EXTENDED RELEASE | ANDA |
| Memantine Hydrochloride | memantine hydrochloride | CAPSULE, EXTENDED RELEASE | ANDA |
| Memantine Hydrochloride | memantine hydrochloride | CAPSULE, EXTENDED RELEASE | ANDA |
| Pramipexole Dihydrochloride | Pramipexole Dihydrochloride | TABLET, EXTENDED RELEASE | ANDA |
| Pramipexole Dihydrochloride Extended-Release | Pramipexole Dihydrochloride | TABLET, EXTENDED RELEASE | ANDA |
| Propafenone Hydrochloride | propafenone | CAPSULE, EXTENDED RELEASE | ANDA |
| Propafenone Hydrochloride | propafenone | CAPSULE, EXTENDED RELEASE | ANDA |
| Propafenone Hydrochloride | propafenone | CAPSULE, EXTENDED RELEASE | ANDA |
| Thyroid | THYROID | TABLET | UNAPPROVED DRUG OTHER |
| Thyroid | THYROID | TABLET | UNAPPROVED DRUG OTHER |
| Thyroid | THYROID | TABLET | UNAPPROVED DRUG OTHER |
| Thyroid | THYROID | TABLET | UNAPPROVED DRUG OTHER |
| Thyroid | THYROID | TABLET | UNAPPROVED DRUG OTHER |
| Topiramate | Topiramate | CAPSULE, EXTENDED RELEASE | ANDA |
| Topiramate | Topiramate | CAPSULE, EXTENDED RELEASE | ANDA |
| Topiramate | Topiramate | CAPSULE, EXTENDED RELEASE | ANDA |
| Topiramate | Topiramate | CAPSULE, EXTENDED RELEASE | ANDA |
| Topiramate | Topiramate | CAPSULE, EXTENDED RELEASE | ANDA |
| memantine hydrochloride and donepezil hydrochloride | memantine hydrochloride and donepezil hydrochloride | CAPSULE, EXTENDED RELEASE | ANDA |
| memantine hydrochloride and donepezil hydrochloride | memantine hydrochloride and donepezil hydrochloride | CAPSULE, EXTENDED RELEASE | ANDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.